[ad_1]
Jim Worden, chief investment officer of the Wealth Consulting Group, is watching out for a lot of money to go rushing back into stocks, lifting all boats.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...